Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W Neal

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Acta Neuropathologica|February 17, 2017
Mixed pathologies including chronic traumatic encephalopathy account for dementia in retired association football (soccer) playersHelen Ling, Huw R Morris, James W Neal, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 2012
C3-dependent mechanism of microglial priming relevant to multiple sclerosisValeria Ramaglia, Timothy R Hughes, Rossen M Donev, et al.
Brain : a Journal of Neurology|June 4, 2019
Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's diseaseJames A R Nicoll, George R Buckland, Charlotte H Harrison, et al.
Acta Neuropathologica Communications|June 3, 2014
Complement activation in multiple sclerosis plaques: an immunohistochemical analysisGillian Ingram, Sam Loveless, Owain W Howell, et al.
Brain : a Journal of Neurology|August 15, 2013
Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunizationElina Zotova, Viraj Bharambe, Matthew Cheaveau, et al.
Journal of Neuroinflammation|June 24, 2016
Complement is activated in progressive multiple sclerosis cortical grey matter lesionsLewis M Watkins, James W Neal, Sam Loveless, et al.
Lancet (London, England)|July 22, 2008
Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trialClive Holmes, Delphine Boche, David Wilkinson, et al.
Frontiers in Cellular Neuroscience|April 10, 2023
Complement activation and increased anaphylatoxin receptor expression are associated with cortical grey matter lesions and the compartmentalised inflammatory response of multiple sclerosisRhian Evans, Lewis M Watkins, Kristen Hawkins, et al.
Brain Pathology (Zurich, Switzerland)|July 15, 2017
Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosisSam Loveless, James W Neal, Owain W Howell, et al.
Brain Pathology (Zurich, Switzerland)|February 8, 2022
The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcomeBenjamin J Cooze, Matthew Dickerson, Rukshikah Loganathan, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Acta Neuropathologica|February 17, 2017
Mixed pathologies including chronic traumatic encephalopathy account for dementia in retired association football (soccer) playersHelen Ling, Huw R Morris, James W Neal, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 2012
C3-dependent mechanism of microglial priming relevant to multiple sclerosisValeria Ramaglia, Timothy R Hughes, Rossen M Donev, et al.
Brain : a Journal of Neurology|June 4, 2019
Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's diseaseJames A R Nicoll, George R Buckland, Charlotte H Harrison, et al.
Acta Neuropathologica Communications|June 3, 2014
Complement activation in multiple sclerosis plaques: an immunohistochemical analysisGillian Ingram, Sam Loveless, Owain W Howell, et al.
Brain : a Journal of Neurology|August 15, 2013
Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunizationElina Zotova, Viraj Bharambe, Matthew Cheaveau, et al.
Journal of Neuroinflammation|June 24, 2016
Complement is activated in progressive multiple sclerosis cortical grey matter lesionsLewis M Watkins, James W Neal, Sam Loveless, et al.
Lancet (London, England)|July 22, 2008
Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trialClive Holmes, Delphine Boche, David Wilkinson, et al.
Frontiers in Cellular Neuroscience|April 10, 2023
Complement activation and increased anaphylatoxin receptor expression are associated with cortical grey matter lesions and the compartmentalised inflammatory response of multiple sclerosisRhian Evans, Lewis M Watkins, Kristen Hawkins, et al.
Brain Pathology (Zurich, Switzerland)|July 15, 2017
Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosisSam Loveless, James W Neal, Owain W Howell, et al.
Brain Pathology (Zurich, Switzerland)|February 8, 2022
The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcomeBenjamin J Cooze, Matthew Dickerson, Rukshikah Loganathan, et al.
Pageof 3